OBJECTIVE: Toward meeting the need for a measure of individual differences in substance use disorder (SUD) liability that is grounded in the multifactorial model of SUD transmission, this investigation tested to what degree transmissible SUD risk is better measured using the continuous Transmissible Liability Index (TLI) (young adult version) compared to alternative contemporary clinical methods. METHOD: Data from 9535 18- to 30-year-olds in the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions, a U.S. representative sample, were used to compute TLI scores and test hypotheses. Other variables were SUDs of each DSM-IV drug class, clinical predictors of SUD treatment outcomes, treatment seeking and usage, age of onset of SUDs and substance use (SU), and eligibility for SUD clinical trials. RESULTS: TLI scores account for variation in SUD risk over and above parental lifetime SUD, conduct and antisocial personality disorder criteria and frequency of SU. SUD risk increases two- to four-fold per standard deviation increment in TLI scores. The TLI is associated with SUD treatment seeking and usage, younger age of onset of SU and SUD, and exclusion from traditional clinical trials of SUD treatment. CONCLUSIONS: The TLI can identify persons with high versus low transmissible SUD risk, worse prognosis of SUD recovery and to whom extant SUD clinical trials results may not generalize. Recreating TLI scores in extant datasets facilitates etiology and applied research on the full range of transmissible SUD risk in development, treatment and recovery without obtaining new samples.
OBJECTIVE: Toward meeting the need for a measure of individual differences in substance use disorder (SUD) liability that is grounded in the multifactorial model of SUD transmission, this investigation tested to what degree transmissible SUD risk is better measured using the continuous Transmissible Liability Index (TLI) (young adult version) compared to alternative contemporary clinical methods. METHOD: Data from 9535 18- to 30-year-olds in the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions, a U.S. representative sample, were used to compute TLI scores and test hypotheses. Other variables were SUDs of each DSM-IV drug class, clinical predictors of SUD treatment outcomes, treatment seeking and usage, age of onset of SUDs and substance use (SU), and eligibility for SUD clinical trials. RESULTS: TLI scores account for variation in SUD risk over and above parental lifetime SUD, conduct and antisocial personality disorder criteria and frequency of SU. SUD risk increases two- to four-fold per standard deviation increment in TLI scores. The TLI is associated with SUD treatment seeking and usage, younger age of onset of SU and SUD, and exclusion from traditional clinical trials of SUD treatment. CONCLUSIONS: The TLI can identify persons with high versus low transmissible SUD risk, worse prognosis of SUD recovery and to whom extant SUD clinical trials results may not generalize. Recreating TLI scores in extant datasets facilitates etiology and applied research on the full range of transmissible SUD risk in development, treatment and recovery without obtaining new samples.
Authors: Howard J Shaffer; Debi A LaPlante; Richard A LaBrie; Rachel C Kidman; Anthony N Donato; Michael V Stanton Journal: Harv Rev Psychiatry Date: 2004 Nov-Dec Impact factor: 3.732
Authors: Laura Jean Bierut; Pamela A F Madden; Naomi Breslau; Eric O Johnson; Dorothy Hatsukami; Ovide F Pomerleau; Gary E Swan; Joni Rutter; Sarah Bertelsen; Louis Fox; Douglas Fugman; Alison M Goate; Anthony L Hinrichs; Karel Konvicka; Nicholas G Martin; Grant W Montgomery; Nancy L Saccone; Scott F Saccone; Jen C Wang; Gary A Chase; John P Rice; Dennis G Ballinger Journal: Hum Mol Genet Date: 2006-12-07 Impact factor: 6.150
Authors: Valerie S Knopik; Andrew C Heath; Pamela A F Madden; Kathleen K Bucholz; Wendy S Slutske; Elliot C Nelson; Dixie Statham; John B Whitfield; Nicholas G Martin Journal: Psychol Med Date: 2004-11 Impact factor: 7.723
Authors: Carlos Blanco; Mayumi Okuda; Crystal Wright; Deborah S Hasin; Bridget F Grant; Shang-Min Liu; Mark Olfson Journal: Arch Gen Psychiatry Date: 2008-12
Authors: Carlos Blanco; Mark Olfson; Mayumi Okuda; Edward V Nunes; Shang-Min Liu; Deborah S Hasin Journal: Drug Alcohol Depend Date: 2008-06-24 Impact factor: 4.492
Authors: W June Ruan; Risë B Goldstein; S Patricia Chou; Sharon M Smith; Tulshi D Saha; Roger P Pickering; Deborah A Dawson; Boji Huang; Frederick S Stinson; Bridget F Grant Journal: Drug Alcohol Depend Date: 2007-08-13 Impact factor: 4.492
Authors: Ralph E Tarter; Levent Kirisci; Ada Mezzich; Ty Ridenour; Diana Fishbein; Michelle Horner; Maureen Reynolds; Galina Kirillova; Michael Vanyukov Journal: Drug Alcohol Depend Date: 2012-02-25 Impact factor: 4.492
Authors: Leslie Hulvershorn; Tom Hummer; Yu-Chien Wu; Ralph Tarter; Parker Rea; Amit Anand; R Andrew Chambers; Peter Finn Journal: Brain Imaging Behav Date: 2018-02 Impact factor: 3.978
Authors: Ty A Ridenour; David Willis; Debra L Bogen; Scott Novak; Jennifer Scherer; Maureen D Reynolds; Zu Wei Zhai; Ralph E Tarter Journal: Drug Alcohol Depend Date: 2015-03-02 Impact factor: 4.492